Trial intelligence / Profile preview

SB-743921 in Non-Hodgkin and Hodgkin Lymphoma

NCT00343564Phase 2Completed

Sponsor
Cytokinetics
Start
Apr 2006
Primary completion
Jul 2010
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of SB-743921 in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Cytokinetics. Started Apr 2006; status: completed.

02

Drugs

SB-743921
03

Conditions

non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)

Beyond the preview

Go deeper on NCT00343564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00343564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call